Objective Because of the lack of Point-of-care testing, the use of low-molecular-weight heparin (LMWH)therapy in some special patients is restricted. This study was designed to determine the in vitro sensitivity to LMWH of different reagents by sonoclot analyser, and to determine whether the ACT can be used to monitor LMWH.
第一作者机构：[1]Beijing Tong Ren Hosp, Dept Cardiol, Beijing, Peoples R China
推荐引用方式(GB/T 7714)：
Shi Xu-Bo,Hu Da-Yi,Wang Jian-Qi,et al.THE SENSITIVITY OF DIFFERENT REAGENTS FOR LABORATORY MONITORING OF LOW MOLECULAR WEIGHT HEPARIN: AN IN VITRO STUDY[J].HEART.2010,96:A54-A55.doi:10.1136/hrt.2010.208967.170.
APA：
Shi Xu-Bo,Hu Da-Yi,Wang Jian-Qi,Chen Zhe,Yu Hai-Rong&Bai Ying.(2010).THE SENSITIVITY OF DIFFERENT REAGENTS FOR LABORATORY MONITORING OF LOW MOLECULAR WEIGHT HEPARIN: AN IN VITRO STUDY.HEART,96,
MLA：
Shi Xu-Bo,et al."THE SENSITIVITY OF DIFFERENT REAGENTS FOR LABORATORY MONITORING OF LOW MOLECULAR WEIGHT HEPARIN: AN IN VITRO STUDY".HEART 96.(2010):A54-A55
医学